By Adedapo Adesanya
The World Health Organisation (WHO), in a new analysis, has revealed that only 46 per cent of people living with diabetes in the African region know their status, raising the risk of severe illness and death, potentially worsening the situation in the region, which already has the world’s highest mortality rates due to the disease.
This is because only 55 per cent of people with diabetes know they have diabetes as the world celebrates World Diabetes Day. This year’s event is being marked today under the theme Access to Care which calls for better access to quality diabetes care as well as the importance of prevention and response.
The global health authority noted that the African region, lack of testing facilities and equipment, inadequate number of trained health personnel, poor access to health facilities, and lack of awareness about diabetes are some of the barriers to diabetes testing.
Currently, 24 million adults are living with diabetes in Africa. The figure is projected to rise by 129 per cent to 55 million by 2045.
In the African region, premature deaths from diabetes (defined as deaths occurring before the age of 70) stand at 58 per cent, higher than the global average of 48 per cent, while the region’s age-standardized death rate (a mathematical adjustment of different populations to have the same structure) for diabetes is 48 per 100 000 population, more than double the global rate of 23 per 100 000. In the region, only one in two people living with type 1 diabetes—the most common form of pediatric diabetes—has access to insulin treatment.
Speaking on this, Dr Matshidiso Moeti, WHO Regional Director for Africa, said, “One of the greatest challenges to diabetes care is lack of diagnosis. Without testing, diabetes becomes a silent killer.
“While countries face several barriers to tackling diabetes, the rising prevalence of the disease is a wakeup call to reinforce health care, improve diagnosis, access to life-saving diabetes medicines, and prioritize diabetes as a major health challenge.”
For the first time ever, countries agreed in May 2022 to key global targets to improve diabetes diagnosis and access to equitable, comprehensive, affordable, and quality treatment and care.
The goals contained in the WHO Global Diabetes Compact aim to have 80 per cent of people living with diabetes diagnosed; 80 per cent of people diagnosed with the disease have good control of blood pressure and blood sugar.
Additionally, countries should strive to ensure all those diagnosed with type 1 diabetes have access to affordable insulin and blood glucose self-monitoring and that 60 per cent of people with diabetes aged 40 years and above have access to cholesterol-lowering drugs. People living with diabetes have a higher risk of hypertension and are prone to high cholesterol—a risk factor for cardiovascular disease—than those without diabetes.
For people living with diabetes, access to affordable treatment, including insulin, is critical to their survival. Limited access to insulin puts their lives in danger. In rural Mozambique, for instance, the life expectancy of a child with type 1 diabetes is as low as seven months. Type 1 diabetes is due to the body’s inability to produce enough insulin, a hormone that regulates blood sugar.
Between 2011 and 2021, the region recorded a five-fold rise in type 1 diabetes among children and teenagers below 19 years, with cases surging from 4 per 1000 children to nearly 20 per 1000.
WHO is supporting African countries to improve their diabetes response. In August 2022, African health ministers endorsed a WHO-led initiative called PEN Plus to increase access to diagnosis, treatment, and care of severe chronic diseases such as diabetes, cardiovascular diseases, and mental and neurotological disorders.
The strategy calls on countries to adopt measures ensuring that essential medicines, technologies and diagnostics are available and accessible at district hospitals. Only 36 per cent of countries in the African region have essential medicines for chronic diseases in public hospitals, according to a 2019 WHO survey.
New Health Reform Bill to Reposition Sector—Osinbajo
By Adedapo Adesanya
Nigeria’s Vice President, Mr Yemi Osinbajo, has disclosed that a new health reform bill to reposition the country’s health sector for improved delivery of set objectives would be in the works soon.
Speaking at the closing of the two-day Presidential Health Reform Committee Retreat in Abuja, he noted that this is pending a full committee report review and a complete policy document appraisal.
“The next steps now are to finalize subcommittee reports for the review of the full committee and produce a full committee report to guide the drafting of the policy document. And then draft a health reform Bill,” Mr Osinbajo stated.
The Vice President then thanked the committee members for their hard work and dedication and reaffirmed the Buhari Administration’s commitment to ensuring that the reform objectives are achieved.
The Vice President emphasized that the federal government’s ongoing efforts to reposition Nigeria’s healthcare delivery system must include collaboration among different levels of government and the private sector to ensure the effective implementation of reforms that will cater to the needs of Nigerians in the 21st century.
It would be recalled that President Muhammadu Buhari had in September 2021, approved the establishment of a Health Sector Reform Committee and appointed the Vice President as Chair of the team, which was officially inaugurated by the VP in January 2022.
The Health Minister, Dr Osagie Ehanire, also a member of the panel, was in attendance at the retreat and also Senator Ibrahim Yahaya Oloriegbe, who is the Chairman of the Senate Committee on Health.
Other members of the committee present at the 2-day retreat included the Emir of Shonga, Haliru Yahaya; DG, Bureau of Public Enterprises (BPE), Mr Alex Okoh; DG, Federal Competition and Consumer Protection Commission (FCCPC), Mr Tunde Irukera; DG, Nigerian Centre for Disease Control (NCDC), Dr Ifedayo Adetifa; Former Coordinator, Presidential Task Force on COVID-19, Dr Sani Aliyu; Lagos State Commissioner of Health, Professor Akin Abayomi; and Lead Coordinator, Presidential Health Reform Committee, Dr Nicholas Audifferen.
Stakeholders Form Coalition Against Counterfeit Pharmaceutical Products
By Dipo Olowookere
Some critical stakeholders in the pharmaceutical industry in Nigeria have come together to form a group aimed at frustrating and subsequently chasing makers of fake and substandard drugs out of business.
The group, known as the Coalition Against Counterfeit Pharmaceutical Products (CACPP), already has the support of the National Agency for Food and Drug Administration and Control (NAFDAC), the major drug manufacturers in the country, distributors, retailers, and others.
At the unveiling of the coalition in Lagos on Monday, the convener of CACPP, Mr Yomi Badejo-Okusanya, who is also the chief executive of CMC Connect, disclosed that the initiative was borne out of the desire to rid the country of counterfeit drugs and save lives of consumers, who take drugs to get better.
“It is borne out of the desire to take a firmer stand against counterfeit pharmaceutical products in Nigeria through engagement and advocacy, with hope to kick off an intense national advocacy campaign against counterfeit pharmaceutical products,” he stated.
He stated that the group has mapped out strategies to achieve these goals, assuring that the coalition was focused and would not be derailed, no matter what.
According to him, CACPP found out that people consume counterfeit pharmaceutical products due to ignorance, poverty, and illiteracy.
While the West Africa Country Manager of Pfizer, Mr Olayinka Subair, agrees with this point, he stressed that, “Counterfeit medicines don’t cure any disease, rather they put patients’ health at risk because of their contents,” noting that fake drugs “ultimately impede the Nigerian healthcare system as lives are lost and medical conditions worsened due to this cankerworm. It is not an individual’s battle; it requires collective effort.”
“Nigerians need to champion the anti-counterfeit cause, especially as regards healthcare. We need to join hands together because there is no shortcut to health. Due process must be followed to get the best results.
“Unlike commodities, fake drugs are life-threatening. This means patients should only buy prescribed medicines from accredited pharmacies and not quacks or roadside vendors,” he stressed.
Also, the Deputy Director of the Federal Task Force on Counterfeit Substandard Regulated Products Investigation and Enforcement at NAFDAC, Mrs Florence Uba, who represented the acting director-general of the agency, assured the group of the full support of the regulatory agency.
However, she emphasised that NAFDAC would not entertain any favouritism as any fake drug maker caught would be severely dealt with, no matter the connection.
In his presentation, the president of the Nigerian Representatives of Overseas Pharmaceutical Manufacturers (NiroPharm), Mr Femi Soremekun, stated that, “In recent years, the fight against counterfeit pharmaceutical products has taken new dimensions due to the global influx of counterfeiting syndicates, it is like a race against time for pharmaceutical companies – the cost to our collective health and economies is enormous.”
“Over the years, pharmaceutical companies have been perplexed as to how best to nip the challenges in the bud. The challenges are overwhelming owing to the sophistication of the activities of counterfeiters.
“Combating counterfeit pharmaceutical products is a herculean task, one that requires strong collaborations between government agencies and key stakeholders because of the impact,” he added.
It was agreed by the stakeholders present at the event yesterday that to combat the illicit trade of counterfeit pharmaceutical products, there is a strong need for collaboration and must look beyond the surface, which is most times in-ward.
Business Post reports that other organisations which threw their full weight behind CACPP include the Pharmaceutical Council of Nigeria (PCN), the Pharmaceutical Society of Nigeria (PSN), and the Pharmaceutical Wholesalers and Distributors Association of Nigeria (PWDAN), among others.
Also, a prominent Nigerian actor and filmmaker, Mr Ayo Badmus, has backed the initiative as its brand ambassador.
Stanbic IBTC Gives Better Conditions for Healthcare Loan
By Aduragbemi Omiyale
Healthcare practitioners intending to get short-term funding support to expand their operations can now do so with better terms from Stanbic IBTC Bank.
The company, which is a subsidiary of Stanbic IBTC Holdings Plc, introduced a package called Healthcare Short-term Loan, which many stakeholders in the health industry have accessed.
In order to make it easier for practitioners to access the credit facility for an improved healthcare sector in the country, the lender has upgraded its short-term loan solution within the healthcare value chain.
This upgrade ensures a flexible repayment period, with an affordable interest rate and zero collateral to enable sector players to access better financing and achieve optimal service delivery.
The healthcare loan, which now offers a longer tenor of 12 months, affordable interest rate and zero collateral, will foster more investment in the sector and enhance strategic relationships to generate new businesses.
Speaking at the Medic West Africa Conference, the Head of Specialized Sectors at Stanbic IBTC Bank, Ms Jane Ike-Okoli, noted that effective collaboration between financial institutions and healthcare organizations is key to advancing Nigeria’s health sector.
She advised financial institutions to be more intentional about complementing the government’s efforts, saying, “Stanbic IBTC has a comprehensive understanding of the healthcare industry and its intricacies. This knowledge inspires us to continue to design innovative yet affordable solutions to boost healthcare businesses across the country.”
According to her, despite Nigeria being Africa’s largest healthcare market, challenges in the health sector include inadequate healthcare infrastructure and insufficient financing.
“Stanbic IBTC is passionate about driving change, hence our partnership with key stakeholders in the healthcare sector to improve access to healthcare finance.
“We achieve this by offering flexible funding options for healthcare businesses and providers and strategically partnering with the players in the healthcare ecosystem,” she said.
“Our healthcare solutions are tailor-made for businesses in the sector who need working capital to expand healthcare operations, acquire medical equipment, facilitate medical research, and ultimately grow their healthcare businesses,” Ms Ike-Okoli added.
The Head of Coverage, Commercial Clients at Stanbic IBTC Bank, Mr Babatunde Akindele, also stated that the newly improved healthcare short-term loan is a necessary investment.
“Healthcare is a basic need that everyone should access easily. The pandemic has increased the pressure on the health sector by revealing the urgent need to expand healthcare facilities. Stanbic IBTC has taken yet another step in the right direction to improve healthcare infrastructure and enable qualitative service delivery, which will restore the hope of many Nigerians,” he said.
The growth of the Nigerian healthcare sector rests on impactful and innovative finance solutions positioned to create a level playing field for businesses to thrive. Stanbic IBTC has said it remains committed to blazing the trail in this regard.
Latest News on Business Post
- House of Reps Tells CBN to Suspend New Cash Withdrawal Limits December 8, 2022
- Finclusion Group Rebrands to Enhance Offerings, Market Footprint December 8, 2022
- GE Reduces Emissions With Mobile Gas Turbines December 8, 2022
- New Cash Withdrawal Policy Was Without Extensive Consultation—NECA December 8, 2022
- SEC Plans to Boost Value of Shariah-Compliant Products to N5trn by 2025 December 8, 2022
- Senate to Screen Ahmad, Adamu as CBN Deputy Governors December 8, 2022
- Airtel Wins 5G Licence Auction in Nigeria December 8, 2022
- Sanwo-Olu Appoints Folasade Coker as Executive Secretary of LJLA December 8, 2022
- Nigeria Needs 10 Years to Meet Yearly Sugar Production Target—Adedeji December 8, 2022
- Naira Appreciates on Dollar at P2P, Black Market, Drops at I&E December 8, 2022